Array ( [body] => Array ( [#theme] => field [#weight] => 0 [#title] => Body [#access] => 1 [#label_display] => hidden [#view_mode] => teaser [#language] => und [#field_name] => body [#field_type] => text_with_summary [#field_translatable] => 0 [#entity_type] => node [#bundle] => box_lancio_news [#object] => stdClass Object ( [vid] => 511477 [uid] => 26499 [title] => GeneRNAtion Challenge - Advancing Personalized Medicine [log] => [status] => 1 [comment] => 0 [promote] => 1 [sticky] => 0 [nid] => 121952 [type] => box_lancio_news [language] => it [created] => 1762507182 [changed] => 1764253054 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1764253054 [revision_uid] => 26499 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>

The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, announces the launch of the first edition of the GeneRNAtion Challenge - Advancing Personalized Medicine. This event represents a unique opportunity to promote the best startups and the most innovative projects in the field of RNA technology and Gene Therapy.

The top eight selected startups will receive a grant of up to 110,000 euros and three years of membership in the National Center for the Development of Gene Therapy and RNA-based Drugs Foundation. The top three research projects will receive a grant of up to 40,000 euros.

Applications are open from November 3, 2025, until January 9, 2026, at 11:59 PM CET.

• The selection results will be communicated by December 21, 2025.
• The Deal Line up, requiring the candidate's availability for a 30-minute slot, will take place by January 18, 2026.
• The awards ceremony will be held by January 31, 2026.

Projects must relate to at least one of the following focus areas of the 10 Spokes of the National Center for RNA & Gene Therapy:

Spoke 1: Genetic Diseases
Spoke 2: Cancer
Spoke 3: Neurodegeneration
Spoke 4: Metabolic and Cardiovascular Diseases
Spoke 5: Inflammatory and Infectious Diseases
Spoke 6: RNA Drug Development
Spoke 7: Biocomputing
Spoke 8: Platforms for RNA/DNA Delivery
Spoke 9: Competence Center on RNA Drug Pharmacology
Spoke 10: Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP
All information and the regulation are available on the dedicated webpage, from which it is possible to download the application form and access the online application procedure.

[summary] => [format] => 2 [safe_value] =>

The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, announces the launch of the first edition of the GeneRNAtion Challenge - Advancing Personalized Medicine. This event represents a unique opportunity to promote the best startups and the most innovative projects in the field of RNA technology and Gene Therapy.

The top eight selected startups will receive a grant of up to 110,000 euros and three years of membership in the National Center for the Development of Gene Therapy and RNA-based Drugs Foundation. The top three research projects will receive a grant of up to 40,000 euros.

Applications are open from November 3, 2025, until January 9, 2026, at 11:59 PM CET.

• The selection results will be communicated by December 21, 2025.
• The Deal Line up, requiring the candidate's availability for a 30-minute slot, will take place by January 18, 2026.
• The awards ceremony will be held by January 31, 2026.

Projects must relate to at least one of the following focus areas of the 10 Spokes of the National Center for RNA & Gene Therapy:

Spoke 1: Genetic Diseases
Spoke 2: Cancer
Spoke 3: Neurodegeneration
Spoke 4: Metabolic and Cardiovascular Diseases
Spoke 5: Inflammatory and Infectious Diseases
Spoke 6: RNA Drug Development
Spoke 7: Biocomputing
Spoke 8: Platforms for RNA/DNA Delivery
Spoke 9: Competence Center on RNA Drug Pharmacology
Spoke 10: Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP
All information and the regulation are available on the dedicated webpage, from which it is possible to download the application form and access the online application procedure.

[safe_summary] => ) ) ) [field_date_box_lancio_news] => Array ( [und] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) ) [field_etichetta_box_lancio_news] => Array ( ) [field_img_box_lancio_news] => Array ( [und] => Array ( [0] => Array ( [fid] => 143846 [uid] => 26499 [filename] => RNA.jpg [uri] => public://RNA.jpg [filemime] => image/jpeg [filesize] => 439007 [status] => 1 [timestamp] => 1762505917 [type] => image [field_file_image_alt_text] => Array ( ) [field_file_image_title_text] => Array ( ) [field_folder] => Array ( [und] => Array ( [0] => Array ( [tid] => 2048 ) ) ) [metadata] => Array ( [height] => 631 [width] => 1200 ) [height] => 631 [width] => 1200 [alt] => rna al microscopio [title] => ) ) ) [field_link_alla_news] => Array ( ) [field_link_esterno_news] => Array ( ) [field_pagina_associata] => Array ( ) [field_link_etichetta] => Array ( ) [field_abstract_news] => Array ( [und] => Array ( [0] => Array ( [value] => The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, is launching the GeneRNAtion Challenge to promote the best startups and the most innovative projects in the field of RNA Technology and Gene Therapy [format] => [safe_value] => The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, is launching the GeneRNAtion Challenge to promote the best startups and the most innovative projects in the field of RNA Technology and Gene Therapy ) ) ) [field_allegato_news] => Array ( ) [field_categorie_news] => Array ( [und] => Array ( [0] => Array ( [tid] => 2296 ) ) ) [field_pub_date] => Array ( [und] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [value2] => 2025-11-30T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) ) [field_layout_news] => Array ( [und] => Array ( [0] => Array ( [value] => single ) ) ) [field_testo_opzionale_news] => Array ( ) [field_url_en_page] => Array ( [und] => Array ( [0] => Array ( [value] => https://www.unipd.it/news/genernation-challenge-advancing-personalized-medicine [format] => [safe_value] => https://www.unipd.it/news/genernation-challenge-advancing-personalized-medicine ) ) ) [field_url_en_page_label] => Array ( [und] => Array ( [0] => Array ( [value] => Versione italiana [format] => [safe_value] => Versione italiana ) ) ) [path] => Array ( [pathauto] => 0 ) [name] => rossella.vezzosi [picture] => 0 [data] => b:0; [num_revisions] => 3 [current_revision_id] => 511477 [is_current] => 1 [is_pending] => [revision_moderation] => [entity_view_prepared] => 1 ) [#items] => Array ( [0] => Array ( [value] =>

The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, announces the launch of the first edition of the GeneRNAtion Challenge - Advancing Personalized Medicine. This event represents a unique opportunity to promote the best startups and the most innovative projects in the field of RNA technology and Gene Therapy.

The top eight selected startups will receive a grant of up to 110,000 euros and three years of membership in the National Center for the Development of Gene Therapy and RNA-based Drugs Foundation. The top three research projects will receive a grant of up to 40,000 euros.

Applications are open from November 3, 2025, until January 9, 2026, at 11:59 PM CET.

• The selection results will be communicated by December 21, 2025.
• The Deal Line up, requiring the candidate's availability for a 30-minute slot, will take place by January 18, 2026.
• The awards ceremony will be held by January 31, 2026.

Projects must relate to at least one of the following focus areas of the 10 Spokes of the National Center for RNA & Gene Therapy:

Spoke 1: Genetic Diseases
Spoke 2: Cancer
Spoke 3: Neurodegeneration
Spoke 4: Metabolic and Cardiovascular Diseases
Spoke 5: Inflammatory and Infectious Diseases
Spoke 6: RNA Drug Development
Spoke 7: Biocomputing
Spoke 8: Platforms for RNA/DNA Delivery
Spoke 9: Competence Center on RNA Drug Pharmacology
Spoke 10: Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP
All information and the regulation are available on the dedicated webpage, from which it is possible to download the application form and access the online application procedure.

[summary] => [format] => 2 [safe_value] =>

The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, announces the launch of the first edition of the GeneRNAtion Challenge - Advancing Personalized Medicine. This event represents a unique opportunity to promote the best startups and the most innovative projects in the field of RNA technology and Gene Therapy.

The top eight selected startups will receive a grant of up to 110,000 euros and three years of membership in the National Center for the Development of Gene Therapy and RNA-based Drugs Foundation. The top three research projects will receive a grant of up to 40,000 euros.

Applications are open from November 3, 2025, until January 9, 2026, at 11:59 PM CET.

• The selection results will be communicated by December 21, 2025.
• The Deal Line up, requiring the candidate's availability for a 30-minute slot, will take place by January 18, 2026.
• The awards ceremony will be held by January 31, 2026.

Projects must relate to at least one of the following focus areas of the 10 Spokes of the National Center for RNA & Gene Therapy:

Spoke 1: Genetic Diseases
Spoke 2: Cancer
Spoke 3: Neurodegeneration
Spoke 4: Metabolic and Cardiovascular Diseases
Spoke 5: Inflammatory and Infectious Diseases
Spoke 6: RNA Drug Development
Spoke 7: Biocomputing
Spoke 8: Platforms for RNA/DNA Delivery
Spoke 9: Competence Center on RNA Drug Pharmacology
Spoke 10: Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP
All information and the regulation are available on the dedicated webpage, from which it is possible to download the application form and access the online application procedure.

[safe_summary] => ) ) [#formatter] => text_summary_or_trimmed [0] => Array ( [#markup] =>

The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, announces the launch of the first edition of the GeneRNAtion Challenge - Advancing Personalized Medicine. This event represents a unique opportunity to promote the best startups and the most innovative projects in the field of RNA technology and Gene Therapy.

) ) [field_img_box_lancio_news] => Array ( [#theme] => field [#weight] => 0 [#title] => Immagine [#access] => 1 [#label_display] => above [#view_mode] => teaser [#language] => und [#field_name] => field_img_box_lancio_news [#field_type] => image [#field_translatable] => 0 [#entity_type] => node [#bundle] => box_lancio_news [#object] => stdClass Object ( [vid] => 511477 [uid] => 26499 [title] => GeneRNAtion Challenge - Advancing Personalized Medicine [log] => [status] => 1 [comment] => 0 [promote] => 1 [sticky] => 0 [nid] => 121952 [type] => box_lancio_news [language] => it [created] => 1762507182 [changed] => 1764253054 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1764253054 [revision_uid] => 26499 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>

The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, announces the launch of the first edition of the GeneRNAtion Challenge - Advancing Personalized Medicine. This event represents a unique opportunity to promote the best startups and the most innovative projects in the field of RNA technology and Gene Therapy.

The top eight selected startups will receive a grant of up to 110,000 euros and three years of membership in the National Center for the Development of Gene Therapy and RNA-based Drugs Foundation. The top three research projects will receive a grant of up to 40,000 euros.

Applications are open from November 3, 2025, until January 9, 2026, at 11:59 PM CET.

• The selection results will be communicated by December 21, 2025.
• The Deal Line up, requiring the candidate's availability for a 30-minute slot, will take place by January 18, 2026.
• The awards ceremony will be held by January 31, 2026.

Projects must relate to at least one of the following focus areas of the 10 Spokes of the National Center for RNA & Gene Therapy:

Spoke 1: Genetic Diseases
Spoke 2: Cancer
Spoke 3: Neurodegeneration
Spoke 4: Metabolic and Cardiovascular Diseases
Spoke 5: Inflammatory and Infectious Diseases
Spoke 6: RNA Drug Development
Spoke 7: Biocomputing
Spoke 8: Platforms for RNA/DNA Delivery
Spoke 9: Competence Center on RNA Drug Pharmacology
Spoke 10: Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP
All information and the regulation are available on the dedicated webpage, from which it is possible to download the application form and access the online application procedure.

[summary] => [format] => 2 [safe_value] =>

The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, announces the launch of the first edition of the GeneRNAtion Challenge - Advancing Personalized Medicine. This event represents a unique opportunity to promote the best startups and the most innovative projects in the field of RNA technology and Gene Therapy.

The top eight selected startups will receive a grant of up to 110,000 euros and three years of membership in the National Center for the Development of Gene Therapy and RNA-based Drugs Foundation. The top three research projects will receive a grant of up to 40,000 euros.

Applications are open from November 3, 2025, until January 9, 2026, at 11:59 PM CET.

• The selection results will be communicated by December 21, 2025.
• The Deal Line up, requiring the candidate's availability for a 30-minute slot, will take place by January 18, 2026.
• The awards ceremony will be held by January 31, 2026.

Projects must relate to at least one of the following focus areas of the 10 Spokes of the National Center for RNA & Gene Therapy:

Spoke 1: Genetic Diseases
Spoke 2: Cancer
Spoke 3: Neurodegeneration
Spoke 4: Metabolic and Cardiovascular Diseases
Spoke 5: Inflammatory and Infectious Diseases
Spoke 6: RNA Drug Development
Spoke 7: Biocomputing
Spoke 8: Platforms for RNA/DNA Delivery
Spoke 9: Competence Center on RNA Drug Pharmacology
Spoke 10: Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP
All information and the regulation are available on the dedicated webpage, from which it is possible to download the application form and access the online application procedure.

[safe_summary] => ) ) ) [field_date_box_lancio_news] => Array ( [und] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) ) [field_etichetta_box_lancio_news] => Array ( ) [field_img_box_lancio_news] => Array ( [und] => Array ( [0] => Array ( [fid] => 143846 [uid] => 26499 [filename] => RNA.jpg [uri] => public://RNA.jpg [filemime] => image/jpeg [filesize] => 439007 [status] => 1 [timestamp] => 1762505917 [type] => image [field_file_image_alt_text] => Array ( ) [field_file_image_title_text] => Array ( ) [field_folder] => Array ( [und] => Array ( [0] => Array ( [tid] => 2048 ) ) ) [metadata] => Array ( [height] => 631 [width] => 1200 ) [height] => 631 [width] => 1200 [alt] => rna al microscopio [title] => ) ) ) [field_link_alla_news] => Array ( ) [field_link_esterno_news] => Array ( ) [field_pagina_associata] => Array ( ) [field_link_etichetta] => Array ( ) [field_abstract_news] => Array ( [und] => Array ( [0] => Array ( [value] => The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, is launching the GeneRNAtion Challenge to promote the best startups and the most innovative projects in the field of RNA Technology and Gene Therapy [format] => [safe_value] => The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, is launching the GeneRNAtion Challenge to promote the best startups and the most innovative projects in the field of RNA Technology and Gene Therapy ) ) ) [field_allegato_news] => Array ( ) [field_categorie_news] => Array ( [und] => Array ( [0] => Array ( [tid] => 2296 ) ) ) [field_pub_date] => Array ( [und] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [value2] => 2025-11-30T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) ) [field_layout_news] => Array ( [und] => Array ( [0] => Array ( [value] => single ) ) ) [field_testo_opzionale_news] => Array ( ) [field_url_en_page] => Array ( [und] => Array ( [0] => Array ( [value] => https://www.unipd.it/news/genernation-challenge-advancing-personalized-medicine [format] => [safe_value] => https://www.unipd.it/news/genernation-challenge-advancing-personalized-medicine ) ) ) [field_url_en_page_label] => Array ( [und] => Array ( [0] => Array ( [value] => Versione italiana [format] => [safe_value] => Versione italiana ) ) ) [path] => Array ( [pathauto] => 0 ) [name] => rossella.vezzosi [picture] => 0 [data] => b:0; [num_revisions] => 3 [current_revision_id] => 511477 [is_current] => 1 [is_pending] => [revision_moderation] => [entity_view_prepared] => 1 ) [#items] => Array ( [0] => Array ( [fid] => 143846 [uid] => 26499 [filename] => RNA.jpg [uri] => public://RNA.jpg [filemime] => image/jpeg [filesize] => 439007 [status] => 1 [timestamp] => 1762505917 [type] => image [field_file_image_alt_text] => Array ( ) [field_file_image_title_text] => Array ( ) [field_folder] => Array ( [und] => Array ( [0] => Array ( [tid] => 2048 ) ) ) [metadata] => Array ( [height] => 631 [width] => 1200 ) [height] => 631 [width] => 1200 [alt] => rna al microscopio [title] => ) ) [#formatter] => image [0] => Array ( [#theme] => image_formatter [#item] => Array ( [fid] => 143846 [uid] => 26499 [filename] => RNA.jpg [uri] => public://RNA.jpg [filemime] => image/jpeg [filesize] => 439007 [status] => 1 [timestamp] => 1762505917 [type] => image [field_file_image_alt_text] => Array ( ) [field_file_image_title_text] => Array ( ) [field_folder] => Array ( [und] => Array ( [0] => Array ( [tid] => 2048 ) ) ) [metadata] => Array ( [height] => 631 [width] => 1200 ) [height] => 631 [width] => 1200 [alt] => rna al microscopio [title] => ) [#image_style] => [#path] => ) ) [field_abstract_news] => Array ( [#theme] => field [#weight] => 0 [#title] => Abstract [#access] => 1 [#label_display] => above [#view_mode] => teaser [#language] => und [#field_name] => field_abstract_news [#field_type] => text_long [#field_translatable] => 0 [#entity_type] => node [#bundle] => box_lancio_news [#object] => stdClass Object ( [vid] => 511477 [uid] => 26499 [title] => GeneRNAtion Challenge - Advancing Personalized Medicine [log] => [status] => 1 [comment] => 0 [promote] => 1 [sticky] => 0 [nid] => 121952 [type] => box_lancio_news [language] => it [created] => 1762507182 [changed] => 1764253054 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1764253054 [revision_uid] => 26499 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>

The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, announces the launch of the first edition of the GeneRNAtion Challenge - Advancing Personalized Medicine. This event represents a unique opportunity to promote the best startups and the most innovative projects in the field of RNA technology and Gene Therapy.

The top eight selected startups will receive a grant of up to 110,000 euros and three years of membership in the National Center for the Development of Gene Therapy and RNA-based Drugs Foundation. The top three research projects will receive a grant of up to 40,000 euros.

Applications are open from November 3, 2025, until January 9, 2026, at 11:59 PM CET.

• The selection results will be communicated by December 21, 2025.
• The Deal Line up, requiring the candidate's availability for a 30-minute slot, will take place by January 18, 2026.
• The awards ceremony will be held by January 31, 2026.

Projects must relate to at least one of the following focus areas of the 10 Spokes of the National Center for RNA & Gene Therapy:

Spoke 1: Genetic Diseases
Spoke 2: Cancer
Spoke 3: Neurodegeneration
Spoke 4: Metabolic and Cardiovascular Diseases
Spoke 5: Inflammatory and Infectious Diseases
Spoke 6: RNA Drug Development
Spoke 7: Biocomputing
Spoke 8: Platforms for RNA/DNA Delivery
Spoke 9: Competence Center on RNA Drug Pharmacology
Spoke 10: Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP
All information and the regulation are available on the dedicated webpage, from which it is possible to download the application form and access the online application procedure.

[summary] => [format] => 2 [safe_value] =>

The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, announces the launch of the first edition of the GeneRNAtion Challenge - Advancing Personalized Medicine. This event represents a unique opportunity to promote the best startups and the most innovative projects in the field of RNA technology and Gene Therapy.

The top eight selected startups will receive a grant of up to 110,000 euros and three years of membership in the National Center for the Development of Gene Therapy and RNA-based Drugs Foundation. The top three research projects will receive a grant of up to 40,000 euros.

Applications are open from November 3, 2025, until January 9, 2026, at 11:59 PM CET.

• The selection results will be communicated by December 21, 2025.
• The Deal Line up, requiring the candidate's availability for a 30-minute slot, will take place by January 18, 2026.
• The awards ceremony will be held by January 31, 2026.

Projects must relate to at least one of the following focus areas of the 10 Spokes of the National Center for RNA & Gene Therapy:

Spoke 1: Genetic Diseases
Spoke 2: Cancer
Spoke 3: Neurodegeneration
Spoke 4: Metabolic and Cardiovascular Diseases
Spoke 5: Inflammatory and Infectious Diseases
Spoke 6: RNA Drug Development
Spoke 7: Biocomputing
Spoke 8: Platforms for RNA/DNA Delivery
Spoke 9: Competence Center on RNA Drug Pharmacology
Spoke 10: Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP
All information and the regulation are available on the dedicated webpage, from which it is possible to download the application form and access the online application procedure.

[safe_summary] => ) ) ) [field_date_box_lancio_news] => Array ( [und] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) ) [field_etichetta_box_lancio_news] => Array ( ) [field_img_box_lancio_news] => Array ( [und] => Array ( [0] => Array ( [fid] => 143846 [uid] => 26499 [filename] => RNA.jpg [uri] => public://RNA.jpg [filemime] => image/jpeg [filesize] => 439007 [status] => 1 [timestamp] => 1762505917 [type] => image [field_file_image_alt_text] => Array ( ) [field_file_image_title_text] => Array ( ) [field_folder] => Array ( [und] => Array ( [0] => Array ( [tid] => 2048 ) ) ) [metadata] => Array ( [height] => 631 [width] => 1200 ) [height] => 631 [width] => 1200 [alt] => rna al microscopio [title] => ) ) ) [field_link_alla_news] => Array ( ) [field_link_esterno_news] => Array ( ) [field_pagina_associata] => Array ( ) [field_link_etichetta] => Array ( ) [field_abstract_news] => Array ( [und] => Array ( [0] => Array ( [value] => The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, is launching the GeneRNAtion Challenge to promote the best startups and the most innovative projects in the field of RNA Technology and Gene Therapy [format] => [safe_value] => The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, is launching the GeneRNAtion Challenge to promote the best startups and the most innovative projects in the field of RNA Technology and Gene Therapy ) ) ) [field_allegato_news] => Array ( ) [field_categorie_news] => Array ( [und] => Array ( [0] => Array ( [tid] => 2296 ) ) ) [field_pub_date] => Array ( [und] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [value2] => 2025-11-30T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) ) [field_layout_news] => Array ( [und] => Array ( [0] => Array ( [value] => single ) ) ) [field_testo_opzionale_news] => Array ( ) [field_url_en_page] => Array ( [und] => Array ( [0] => Array ( [value] => https://www.unipd.it/news/genernation-challenge-advancing-personalized-medicine [format] => [safe_value] => https://www.unipd.it/news/genernation-challenge-advancing-personalized-medicine ) ) ) [field_url_en_page_label] => Array ( [und] => Array ( [0] => Array ( [value] => Versione italiana [format] => [safe_value] => Versione italiana ) ) ) [path] => Array ( [pathauto] => 0 ) [name] => rossella.vezzosi [picture] => 0 [data] => b:0; [num_revisions] => 3 [current_revision_id] => 511477 [is_current] => 1 [is_pending] => [revision_moderation] => [entity_view_prepared] => 1 ) [#items] => Array ( [0] => Array ( [value] => The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, is launching the GeneRNAtion Challenge to promote the best startups and the most innovative projects in the field of RNA Technology and Gene Therapy [format] => [safe_value] => The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, is launching the GeneRNAtion Challenge to promote the best startups and the most innovative projects in the field of RNA Technology and Gene Therapy ) ) [#formatter] => text_default [0] => Array ( [#markup] => The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, is launching the GeneRNAtion Challenge to promote the best startups and the most innovative projects in the field of RNA Technology and Gene Therapy ) ) [links] => Array ( [#theme] => links__node [#pre_render] => Array ( [0] => drupal_pre_render_links ) [#attributes] => Array ( [class] => Array ( [0] => links [1] => inline ) ) [node] => Array ( [#theme] => links__node__node [#links] => Array ( [node-readmore] => Array ( [title] => Read more about GeneRNAtion Challenge - Advancing Personalized Medicine [href] => node/121952 [html] => 1 [attributes] => Array ( [rel] => tag [title] => GeneRNAtion Challenge - Advancing Personalized Medicine ) ) ) [#attributes] => Array ( [class] => Array ( [0] => links [1] => inline ) ) ) ) [field_date_box_lancio_news] => Array ( [#theme] => field [#weight] => 1 [#title] => Data [#access] => 1 [#label_display] => above [#view_mode] => teaser [#language] => und [#field_name] => field_date_box_lancio_news [#field_type] => date [#field_translatable] => 0 [#entity_type] => node [#bundle] => box_lancio_news [#object] => stdClass Object ( [vid] => 511477 [uid] => 26499 [title] => GeneRNAtion Challenge - Advancing Personalized Medicine [log] => [status] => 1 [comment] => 0 [promote] => 1 [sticky] => 0 [nid] => 121952 [type] => box_lancio_news [language] => it [created] => 1762507182 [changed] => 1764253054 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1764253054 [revision_uid] => 26499 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>

The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, announces the launch of the first edition of the GeneRNAtion Challenge - Advancing Personalized Medicine. This event represents a unique opportunity to promote the best startups and the most innovative projects in the field of RNA technology and Gene Therapy.

The top eight selected startups will receive a grant of up to 110,000 euros and three years of membership in the National Center for the Development of Gene Therapy and RNA-based Drugs Foundation. The top three research projects will receive a grant of up to 40,000 euros.

Applications are open from November 3, 2025, until January 9, 2026, at 11:59 PM CET.

• The selection results will be communicated by December 21, 2025.
• The Deal Line up, requiring the candidate's availability for a 30-minute slot, will take place by January 18, 2026.
• The awards ceremony will be held by January 31, 2026.

Projects must relate to at least one of the following focus areas of the 10 Spokes of the National Center for RNA & Gene Therapy:

Spoke 1: Genetic Diseases
Spoke 2: Cancer
Spoke 3: Neurodegeneration
Spoke 4: Metabolic and Cardiovascular Diseases
Spoke 5: Inflammatory and Infectious Diseases
Spoke 6: RNA Drug Development
Spoke 7: Biocomputing
Spoke 8: Platforms for RNA/DNA Delivery
Spoke 9: Competence Center on RNA Drug Pharmacology
Spoke 10: Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP
All information and the regulation are available on the dedicated webpage, from which it is possible to download the application form and access the online application procedure.

[summary] => [format] => 2 [safe_value] =>

The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, announces the launch of the first edition of the GeneRNAtion Challenge - Advancing Personalized Medicine. This event represents a unique opportunity to promote the best startups and the most innovative projects in the field of RNA technology and Gene Therapy.

The top eight selected startups will receive a grant of up to 110,000 euros and three years of membership in the National Center for the Development of Gene Therapy and RNA-based Drugs Foundation. The top three research projects will receive a grant of up to 40,000 euros.

Applications are open from November 3, 2025, until January 9, 2026, at 11:59 PM CET.

• The selection results will be communicated by December 21, 2025.
• The Deal Line up, requiring the candidate's availability for a 30-minute slot, will take place by January 18, 2026.
• The awards ceremony will be held by January 31, 2026.

Projects must relate to at least one of the following focus areas of the 10 Spokes of the National Center for RNA & Gene Therapy:

Spoke 1: Genetic Diseases
Spoke 2: Cancer
Spoke 3: Neurodegeneration
Spoke 4: Metabolic and Cardiovascular Diseases
Spoke 5: Inflammatory and Infectious Diseases
Spoke 6: RNA Drug Development
Spoke 7: Biocomputing
Spoke 8: Platforms for RNA/DNA Delivery
Spoke 9: Competence Center on RNA Drug Pharmacology
Spoke 10: Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP
All information and the regulation are available on the dedicated webpage, from which it is possible to download the application form and access the online application procedure.

[safe_summary] => ) ) ) [field_date_box_lancio_news] => Array ( [und] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) ) [field_etichetta_box_lancio_news] => Array ( ) [field_img_box_lancio_news] => Array ( [und] => Array ( [0] => Array ( [fid] => 143846 [uid] => 26499 [filename] => RNA.jpg [uri] => public://RNA.jpg [filemime] => image/jpeg [filesize] => 439007 [status] => 1 [timestamp] => 1762505917 [type] => image [field_file_image_alt_text] => Array ( ) [field_file_image_title_text] => Array ( ) [field_folder] => Array ( [und] => Array ( [0] => Array ( [tid] => 2048 ) ) ) [metadata] => Array ( [height] => 631 [width] => 1200 ) [height] => 631 [width] => 1200 [alt] => rna al microscopio [title] => ) ) ) [field_link_alla_news] => Array ( ) [field_link_esterno_news] => Array ( ) [field_pagina_associata] => Array ( ) [field_link_etichetta] => Array ( ) [field_abstract_news] => Array ( [und] => Array ( [0] => Array ( [value] => The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, is launching the GeneRNAtion Challenge to promote the best startups and the most innovative projects in the field of RNA Technology and Gene Therapy [format] => [safe_value] => The National Center for Gene Therapy and RNA Drugs, in collaboration with Intesa Sanpaolo Innovation Center, is launching the GeneRNAtion Challenge to promote the best startups and the most innovative projects in the field of RNA Technology and Gene Therapy ) ) ) [field_allegato_news] => Array ( ) [field_categorie_news] => Array ( [und] => Array ( [0] => Array ( [tid] => 2296 ) ) ) [field_pub_date] => Array ( [und] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [value2] => 2025-11-30T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) ) [field_layout_news] => Array ( [und] => Array ( [0] => Array ( [value] => single ) ) ) [field_testo_opzionale_news] => Array ( ) [field_url_en_page] => Array ( [und] => Array ( [0] => Array ( [value] => https://www.unipd.it/news/genernation-challenge-advancing-personalized-medicine [format] => [safe_value] => https://www.unipd.it/news/genernation-challenge-advancing-personalized-medicine ) ) ) [field_url_en_page_label] => Array ( [und] => Array ( [0] => Array ( [value] => Versione italiana [format] => [safe_value] => Versione italiana ) ) ) [path] => Array ( [pathauto] => 0 ) [name] => rossella.vezzosi [picture] => 0 [data] => b:0; [num_revisions] => 3 [current_revision_id] => 511477 [is_current] => 1 [is_pending] => [revision_moderation] => [entity_view_prepared] => 1 ) [#items] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) [#formatter] => date_default [0] => Array ( [#markup] => Ven, 07/11/2025 ) ) )

Array ( [body] => Array ( [#theme] => field [#weight] => 0 [#title] => Body [#access] => 1 [#label_display] => hidden [#view_mode] => teaser [#language] => und [#field_name] => body [#field_type] => text_with_summary [#field_translatable] => 0 [#entity_type] => node [#bundle] => box_lancio_news [#object] => stdClass Object ( [vid] => 511474 [uid] => 26499 [title] => GeneRNAtion Challenge - Advancing Personalized Medicine [log] => [status] => 1 [comment] => 0 [promote] => 1 [sticky] => 0 [nid] => 121951 [type] => box_lancio_news [language] => it [created] => 1762505917 [changed] => 1764252889 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1764252889 [revision_uid] => 26499 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>

Il Centro Nazionale per la Terapia Genica e Farmaci RNA, in collaborazione con Intesa Sanpaolo Innovation Center, annuncia il lancio della prima edizione della GeneRNAtion Challenge - Advancing Personalized Medicine. Questo evento rappresenta un'opportunità unica per promuovere le migliori startup e i progetti più innovativi nel campo della tecnologia a Rna e della terapia Genica.

Le migliori otto startup selezionate avranno accesso a un contributo in denaro fino a 110.000 euro a fondo perduto e a tre anni di quota di partecipazione alla Fondazione centro nazionale per lo sviluppo di terapia genica e farmaci con tecnologia a Rna. I migliori tre progetti di ricerca riceveranno un contributo in denaro fino a 40.000 euro a fondo perduto.

Le candidature sono aperte dal 3 novembre 2025 fino al 9 gennaio 2026, ore 23:59 CET

• Gli esiti della selezione sono comunicati entro il 21 dicembre 2025.
• La Deal Line up, che richiede la disponibilità del candidato per uno slot di 30 minuti, si svolge entro il 18 gennaio 2026.
• La premiazione avverrà entro il 31 gennaio 2026.

I progetti devono essere attinenti ad almeno uno degli ambiti di riferimento dei 10 Spoke del Centro Nazionale RNA&GeneTherapy elencati di seguito:

Spoke 1 - Genetic Diseases
Spoke 2 - Cancer
Spoke 3 – Neurodegeneration
Spoke 4 - Metabolic and Cardiovascular Diseases
Spoke 5 - Inflammatory and Infectious Diseases
Spoke 6 - RNA Drug Development
Spoke 7 – Biocomputing
Spoke 8 - Platforms for RNA/DNA Delivery
Spoke 9 - Competence Center on RNA Drug Pharmacology
Spoke 10 - Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP

Tutte le informazioni e il regolamento sono disponibili alla pagina web dedicata dalla quale è possibile scaricare il form di candidatura, e accedere alla procedura di candidatura online.

[summary] => [format] => 2 [safe_value] =>

Il Centro Nazionale per la Terapia Genica e Farmaci RNA, in collaborazione con Intesa Sanpaolo Innovation Center, annuncia il lancio della prima edizione della GeneRNAtion Challenge - Advancing Personalized Medicine. Questo evento rappresenta un'opportunità unica per promuovere le migliori startup e i progetti più innovativi nel campo della tecnologia a Rna e della terapia Genica.

Le migliori otto startup selezionate avranno accesso a un contributo in denaro fino a 110.000 euro a fondo perduto e a tre anni di quota di partecipazione alla Fondazione centro nazionale per lo sviluppo di terapia genica e farmaci con tecnologia a Rna. I migliori tre progetti di ricerca riceveranno un contributo in denaro fino a 40.000 euro a fondo perduto.

Le candidature sono aperte dal 3 novembre 2025 fino al 9 gennaio 2026, ore 23:59 CET

• Gli esiti della selezione sono comunicati entro il 21 dicembre 2025.
• La Deal Line up, che richiede la disponibilità del candidato per uno slot di 30 minuti, si svolge entro il 18 gennaio 2026.
• La premiazione avverrà entro il 31 gennaio 2026.

I progetti devono essere attinenti ad almeno uno degli ambiti di riferimento dei 10 Spoke del Centro Nazionale RNA&GeneTherapy elencati di seguito:

Spoke 1 - Genetic Diseases
Spoke 2 - Cancer
Spoke 3 – Neurodegeneration
Spoke 4 - Metabolic and Cardiovascular Diseases
Spoke 5 - Inflammatory and Infectious Diseases
Spoke 6 - RNA Drug Development
Spoke 7 – Biocomputing
Spoke 8 - Platforms for RNA/DNA Delivery
Spoke 9 - Competence Center on RNA Drug Pharmacology
Spoke 10 - Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP

Tutte le informazioni e il regolamento sono disponibili alla pagina web dedicata dalla quale è possibile scaricare il form di candidatura, e accedere alla procedura di candidatura online.

[safe_summary] => ) ) ) [field_date_box_lancio_news] => Array ( [und] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) ) [field_etichetta_box_lancio_news] => Array ( ) [field_img_box_lancio_news] => Array ( [und] => Array ( [0] => Array ( [fid] => 143846 [uid] => 26499 [filename] => RNA.jpg [uri] => public://RNA.jpg [filemime] => image/jpeg [filesize] => 439007 [status] => 1 [timestamp] => 1762505917 [type] => image [field_file_image_alt_text] => Array ( ) [field_file_image_title_text] => Array ( ) [field_folder] => Array ( [und] => Array ( [0] => Array ( [tid] => 2048 ) ) ) [metadata] => Array ( [height] => 631 [width] => 1200 ) [height] => 631 [width] => 1200 [alt] => rna al microscopio [title] => ) ) ) [field_link_alla_news] => Array ( ) [field_link_esterno_news] => Array ( ) [field_pagina_associata] => Array ( ) [field_link_etichetta] => Array ( ) [field_abstract_news] => Array ( [und] => Array ( [0] => Array ( [value] => Il Centro Nazionale per la Terapia Genica e Farmaci RNA in collaborazione con Intesa Sanpaolo Innovation Center, lanciano GeneRNAtion Challenge, per promuovere le migliori startup e i migliori progetti innovativi nel campo della Tecnologia a RNA e della Terapia Genica [format] => [safe_value] => Il Centro Nazionale per la Terapia Genica e Farmaci RNA in collaborazione con Intesa Sanpaolo Innovation Center, lanciano GeneRNAtion Challenge, per promuovere le migliori startup e i migliori progetti innovativi nel campo della Tecnologia a RNA e della Terapia Genica ) ) ) [field_allegato_news] => Array ( ) [field_categorie_news] => Array ( [und] => Array ( [0] => Array ( [tid] => 2264 ) [1] => Array ( [tid] => 2266 ) [2] => Array ( [tid] => 2267 ) [3] => Array ( [tid] => 2462 ) ) ) [field_pub_date] => Array ( [und] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [value2] => 2025-11-30T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) ) [field_layout_news] => Array ( [und] => Array ( [0] => Array ( [value] => single ) ) ) [field_testo_opzionale_news] => Array ( ) [field_url_en_page] => Array ( [und] => Array ( [0] => Array ( [value] => https://www.unipd.it/news/genernation-challenge-advancing-personalized-medicine-0 [format] => [safe_value] => https://www.unipd.it/news/genernation-challenge-advancing-personalized-medicine-0 ) ) ) [field_url_en_page_label] => Array ( [und] => Array ( [0] => Array ( [value] => English version [format] => [safe_value] => English version ) ) ) [path] => Array ( [pathauto] => 1 ) [name] => rossella.vezzosi [picture] => 0 [data] => b:0; [num_revisions] => 5 [current_revision_id] => 511474 [is_current] => 1 [is_pending] => [revision_moderation] => [entity_view_prepared] => 1 ) [#items] => Array ( [0] => Array ( [value] =>

Il Centro Nazionale per la Terapia Genica e Farmaci RNA, in collaborazione con Intesa Sanpaolo Innovation Center, annuncia il lancio della prima edizione della GeneRNAtion Challenge - Advancing Personalized Medicine. Questo evento rappresenta un'opportunità unica per promuovere le migliori startup e i progetti più innovativi nel campo della tecnologia a Rna e della terapia Genica.

Le migliori otto startup selezionate avranno accesso a un contributo in denaro fino a 110.000 euro a fondo perduto e a tre anni di quota di partecipazione alla Fondazione centro nazionale per lo sviluppo di terapia genica e farmaci con tecnologia a Rna. I migliori tre progetti di ricerca riceveranno un contributo in denaro fino a 40.000 euro a fondo perduto.

Le candidature sono aperte dal 3 novembre 2025 fino al 9 gennaio 2026, ore 23:59 CET

• Gli esiti della selezione sono comunicati entro il 21 dicembre 2025.
• La Deal Line up, che richiede la disponibilità del candidato per uno slot di 30 minuti, si svolge entro il 18 gennaio 2026.
• La premiazione avverrà entro il 31 gennaio 2026.

I progetti devono essere attinenti ad almeno uno degli ambiti di riferimento dei 10 Spoke del Centro Nazionale RNA&GeneTherapy elencati di seguito:

Spoke 1 - Genetic Diseases
Spoke 2 - Cancer
Spoke 3 – Neurodegeneration
Spoke 4 - Metabolic and Cardiovascular Diseases
Spoke 5 - Inflammatory and Infectious Diseases
Spoke 6 - RNA Drug Development
Spoke 7 – Biocomputing
Spoke 8 - Platforms for RNA/DNA Delivery
Spoke 9 - Competence Center on RNA Drug Pharmacology
Spoke 10 - Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP

Tutte le informazioni e il regolamento sono disponibili alla pagina web dedicata dalla quale è possibile scaricare il form di candidatura, e accedere alla procedura di candidatura online.

[summary] => [format] => 2 [safe_value] =>

Il Centro Nazionale per la Terapia Genica e Farmaci RNA, in collaborazione con Intesa Sanpaolo Innovation Center, annuncia il lancio della prima edizione della GeneRNAtion Challenge - Advancing Personalized Medicine. Questo evento rappresenta un'opportunità unica per promuovere le migliori startup e i progetti più innovativi nel campo della tecnologia a Rna e della terapia Genica.

Le migliori otto startup selezionate avranno accesso a un contributo in denaro fino a 110.000 euro a fondo perduto e a tre anni di quota di partecipazione alla Fondazione centro nazionale per lo sviluppo di terapia genica e farmaci con tecnologia a Rna. I migliori tre progetti di ricerca riceveranno un contributo in denaro fino a 40.000 euro a fondo perduto.

Le candidature sono aperte dal 3 novembre 2025 fino al 9 gennaio 2026, ore 23:59 CET

• Gli esiti della selezione sono comunicati entro il 21 dicembre 2025.
• La Deal Line up, che richiede la disponibilità del candidato per uno slot di 30 minuti, si svolge entro il 18 gennaio 2026.
• La premiazione avverrà entro il 31 gennaio 2026.

I progetti devono essere attinenti ad almeno uno degli ambiti di riferimento dei 10 Spoke del Centro Nazionale RNA&GeneTherapy elencati di seguito:

Spoke 1 - Genetic Diseases
Spoke 2 - Cancer
Spoke 3 – Neurodegeneration
Spoke 4 - Metabolic and Cardiovascular Diseases
Spoke 5 - Inflammatory and Infectious Diseases
Spoke 6 - RNA Drug Development
Spoke 7 – Biocomputing
Spoke 8 - Platforms for RNA/DNA Delivery
Spoke 9 - Competence Center on RNA Drug Pharmacology
Spoke 10 - Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP

Tutte le informazioni e il regolamento sono disponibili alla pagina web dedicata dalla quale è possibile scaricare il form di candidatura, e accedere alla procedura di candidatura online.

[safe_summary] => ) ) [#formatter] => text_summary_or_trimmed [0] => Array ( [#markup] =>

Il Centro Nazionale per la Terapia Genica e Farmaci RNA, in collaborazione con Intesa Sanpaolo Innovation Center, annuncia il lancio della prima edizione della GeneRNAtion Challenge - Advancing Personalized Medicine. Questo evento rappresenta un'opportunità unica per promuovere le migliori startup e i progetti più innovativi nel campo della tecnologia a Rna e della terapia Genica.

) ) [field_img_box_lancio_news] => Array ( [#theme] => field [#weight] => 0 [#title] => Immagine [#access] => 1 [#label_display] => above [#view_mode] => teaser [#language] => und [#field_name] => field_img_box_lancio_news [#field_type] => image [#field_translatable] => 0 [#entity_type] => node [#bundle] => box_lancio_news [#object] => stdClass Object ( [vid] => 511474 [uid] => 26499 [title] => GeneRNAtion Challenge - Advancing Personalized Medicine [log] => [status] => 1 [comment] => 0 [promote] => 1 [sticky] => 0 [nid] => 121951 [type] => box_lancio_news [language] => it [created] => 1762505917 [changed] => 1764252889 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1764252889 [revision_uid] => 26499 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>

Il Centro Nazionale per la Terapia Genica e Farmaci RNA, in collaborazione con Intesa Sanpaolo Innovation Center, annuncia il lancio della prima edizione della GeneRNAtion Challenge - Advancing Personalized Medicine. Questo evento rappresenta un'opportunità unica per promuovere le migliori startup e i progetti più innovativi nel campo della tecnologia a Rna e della terapia Genica.

Le migliori otto startup selezionate avranno accesso a un contributo in denaro fino a 110.000 euro a fondo perduto e a tre anni di quota di partecipazione alla Fondazione centro nazionale per lo sviluppo di terapia genica e farmaci con tecnologia a Rna. I migliori tre progetti di ricerca riceveranno un contributo in denaro fino a 40.000 euro a fondo perduto.

Le candidature sono aperte dal 3 novembre 2025 fino al 9 gennaio 2026, ore 23:59 CET

• Gli esiti della selezione sono comunicati entro il 21 dicembre 2025.
• La Deal Line up, che richiede la disponibilità del candidato per uno slot di 30 minuti, si svolge entro il 18 gennaio 2026.
• La premiazione avverrà entro il 31 gennaio 2026.

I progetti devono essere attinenti ad almeno uno degli ambiti di riferimento dei 10 Spoke del Centro Nazionale RNA&GeneTherapy elencati di seguito:

Spoke 1 - Genetic Diseases
Spoke 2 - Cancer
Spoke 3 – Neurodegeneration
Spoke 4 - Metabolic and Cardiovascular Diseases
Spoke 5 - Inflammatory and Infectious Diseases
Spoke 6 - RNA Drug Development
Spoke 7 – Biocomputing
Spoke 8 - Platforms for RNA/DNA Delivery
Spoke 9 - Competence Center on RNA Drug Pharmacology
Spoke 10 - Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP

Tutte le informazioni e il regolamento sono disponibili alla pagina web dedicata dalla quale è possibile scaricare il form di candidatura, e accedere alla procedura di candidatura online.

[summary] => [format] => 2 [safe_value] =>

Il Centro Nazionale per la Terapia Genica e Farmaci RNA, in collaborazione con Intesa Sanpaolo Innovation Center, annuncia il lancio della prima edizione della GeneRNAtion Challenge - Advancing Personalized Medicine. Questo evento rappresenta un'opportunità unica per promuovere le migliori startup e i progetti più innovativi nel campo della tecnologia a Rna e della terapia Genica.

Le migliori otto startup selezionate avranno accesso a un contributo in denaro fino a 110.000 euro a fondo perduto e a tre anni di quota di partecipazione alla Fondazione centro nazionale per lo sviluppo di terapia genica e farmaci con tecnologia a Rna. I migliori tre progetti di ricerca riceveranno un contributo in denaro fino a 40.000 euro a fondo perduto.

Le candidature sono aperte dal 3 novembre 2025 fino al 9 gennaio 2026, ore 23:59 CET

• Gli esiti della selezione sono comunicati entro il 21 dicembre 2025.
• La Deal Line up, che richiede la disponibilità del candidato per uno slot di 30 minuti, si svolge entro il 18 gennaio 2026.
• La premiazione avverrà entro il 31 gennaio 2026.

I progetti devono essere attinenti ad almeno uno degli ambiti di riferimento dei 10 Spoke del Centro Nazionale RNA&GeneTherapy elencati di seguito:

Spoke 1 - Genetic Diseases
Spoke 2 - Cancer
Spoke 3 – Neurodegeneration
Spoke 4 - Metabolic and Cardiovascular Diseases
Spoke 5 - Inflammatory and Infectious Diseases
Spoke 6 - RNA Drug Development
Spoke 7 – Biocomputing
Spoke 8 - Platforms for RNA/DNA Delivery
Spoke 9 - Competence Center on RNA Drug Pharmacology
Spoke 10 - Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP

Tutte le informazioni e il regolamento sono disponibili alla pagina web dedicata dalla quale è possibile scaricare il form di candidatura, e accedere alla procedura di candidatura online.

[safe_summary] => ) ) ) [field_date_box_lancio_news] => Array ( [und] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) ) [field_etichetta_box_lancio_news] => Array ( ) [field_img_box_lancio_news] => Array ( [und] => Array ( [0] => Array ( [fid] => 143846 [uid] => 26499 [filename] => RNA.jpg [uri] => public://RNA.jpg [filemime] => image/jpeg [filesize] => 439007 [status] => 1 [timestamp] => 1762505917 [type] => image [field_file_image_alt_text] => Array ( ) [field_file_image_title_text] => Array ( ) [field_folder] => Array ( [und] => Array ( [0] => Array ( [tid] => 2048 ) ) ) [metadata] => Array ( [height] => 631 [width] => 1200 ) [height] => 631 [width] => 1200 [alt] => rna al microscopio [title] => ) ) ) [field_link_alla_news] => Array ( ) [field_link_esterno_news] => Array ( ) [field_pagina_associata] => Array ( ) [field_link_etichetta] => Array ( ) [field_abstract_news] => Array ( [und] => Array ( [0] => Array ( [value] => Il Centro Nazionale per la Terapia Genica e Farmaci RNA in collaborazione con Intesa Sanpaolo Innovation Center, lanciano GeneRNAtion Challenge, per promuovere le migliori startup e i migliori progetti innovativi nel campo della Tecnologia a RNA e della Terapia Genica [format] => [safe_value] => Il Centro Nazionale per la Terapia Genica e Farmaci RNA in collaborazione con Intesa Sanpaolo Innovation Center, lanciano GeneRNAtion Challenge, per promuovere le migliori startup e i migliori progetti innovativi nel campo della Tecnologia a RNA e della Terapia Genica ) ) ) [field_allegato_news] => Array ( ) [field_categorie_news] => Array ( [und] => Array ( [0] => Array ( [tid] => 2264 ) [1] => Array ( [tid] => 2266 ) [2] => Array ( [tid] => 2267 ) [3] => Array ( [tid] => 2462 ) ) ) [field_pub_date] => Array ( [und] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [value2] => 2025-11-30T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) ) [field_layout_news] => Array ( [und] => Array ( [0] => Array ( [value] => single ) ) ) [field_testo_opzionale_news] => Array ( ) [field_url_en_page] => Array ( [und] => Array ( [0] => Array ( [value] => https://www.unipd.it/news/genernation-challenge-advancing-personalized-medicine-0 [format] => [safe_value] => https://www.unipd.it/news/genernation-challenge-advancing-personalized-medicine-0 ) ) ) [field_url_en_page_label] => Array ( [und] => Array ( [0] => Array ( [value] => English version [format] => [safe_value] => English version ) ) ) [path] => Array ( [pathauto] => 1 ) [name] => rossella.vezzosi [picture] => 0 [data] => b:0; [num_revisions] => 5 [current_revision_id] => 511474 [is_current] => 1 [is_pending] => [revision_moderation] => [entity_view_prepared] => 1 ) [#items] => Array ( [0] => Array ( [fid] => 143846 [uid] => 26499 [filename] => RNA.jpg [uri] => public://RNA.jpg [filemime] => image/jpeg [filesize] => 439007 [status] => 1 [timestamp] => 1762505917 [type] => image [field_file_image_alt_text] => Array ( ) [field_file_image_title_text] => Array ( ) [field_folder] => Array ( [und] => Array ( [0] => Array ( [tid] => 2048 ) ) ) [metadata] => Array ( [height] => 631 [width] => 1200 ) [height] => 631 [width] => 1200 [alt] => rna al microscopio [title] => ) ) [#formatter] => image [0] => Array ( [#theme] => image_formatter [#item] => Array ( [fid] => 143846 [uid] => 26499 [filename] => RNA.jpg [uri] => public://RNA.jpg [filemime] => image/jpeg [filesize] => 439007 [status] => 1 [timestamp] => 1762505917 [type] => image [field_file_image_alt_text] => Array ( ) [field_file_image_title_text] => Array ( ) [field_folder] => Array ( [und] => Array ( [0] => Array ( [tid] => 2048 ) ) ) [metadata] => Array ( [height] => 631 [width] => 1200 ) [height] => 631 [width] => 1200 [alt] => rna al microscopio [title] => ) [#image_style] => [#path] => ) ) [field_abstract_news] => Array ( [#theme] => field [#weight] => 0 [#title] => Abstract [#access] => 1 [#label_display] => above [#view_mode] => teaser [#language] => und [#field_name] => field_abstract_news [#field_type] => text_long [#field_translatable] => 0 [#entity_type] => node [#bundle] => box_lancio_news [#object] => stdClass Object ( [vid] => 511474 [uid] => 26499 [title] => GeneRNAtion Challenge - Advancing Personalized Medicine [log] => [status] => 1 [comment] => 0 [promote] => 1 [sticky] => 0 [nid] => 121951 [type] => box_lancio_news [language] => it [created] => 1762505917 [changed] => 1764252889 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1764252889 [revision_uid] => 26499 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>

Il Centro Nazionale per la Terapia Genica e Farmaci RNA, in collaborazione con Intesa Sanpaolo Innovation Center, annuncia il lancio della prima edizione della GeneRNAtion Challenge - Advancing Personalized Medicine. Questo evento rappresenta un'opportunità unica per promuovere le migliori startup e i progetti più innovativi nel campo della tecnologia a Rna e della terapia Genica.

Le migliori otto startup selezionate avranno accesso a un contributo in denaro fino a 110.000 euro a fondo perduto e a tre anni di quota di partecipazione alla Fondazione centro nazionale per lo sviluppo di terapia genica e farmaci con tecnologia a Rna. I migliori tre progetti di ricerca riceveranno un contributo in denaro fino a 40.000 euro a fondo perduto.

Le candidature sono aperte dal 3 novembre 2025 fino al 9 gennaio 2026, ore 23:59 CET

• Gli esiti della selezione sono comunicati entro il 21 dicembre 2025.
• La Deal Line up, che richiede la disponibilità del candidato per uno slot di 30 minuti, si svolge entro il 18 gennaio 2026.
• La premiazione avverrà entro il 31 gennaio 2026.

I progetti devono essere attinenti ad almeno uno degli ambiti di riferimento dei 10 Spoke del Centro Nazionale RNA&GeneTherapy elencati di seguito:

Spoke 1 - Genetic Diseases
Spoke 2 - Cancer
Spoke 3 – Neurodegeneration
Spoke 4 - Metabolic and Cardiovascular Diseases
Spoke 5 - Inflammatory and Infectious Diseases
Spoke 6 - RNA Drug Development
Spoke 7 – Biocomputing
Spoke 8 - Platforms for RNA/DNA Delivery
Spoke 9 - Competence Center on RNA Drug Pharmacology
Spoke 10 - Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP

Tutte le informazioni e il regolamento sono disponibili alla pagina web dedicata dalla quale è possibile scaricare il form di candidatura, e accedere alla procedura di candidatura online.

[summary] => [format] => 2 [safe_value] =>

Il Centro Nazionale per la Terapia Genica e Farmaci RNA, in collaborazione con Intesa Sanpaolo Innovation Center, annuncia il lancio della prima edizione della GeneRNAtion Challenge - Advancing Personalized Medicine. Questo evento rappresenta un'opportunità unica per promuovere le migliori startup e i progetti più innovativi nel campo della tecnologia a Rna e della terapia Genica.

Le migliori otto startup selezionate avranno accesso a un contributo in denaro fino a 110.000 euro a fondo perduto e a tre anni di quota di partecipazione alla Fondazione centro nazionale per lo sviluppo di terapia genica e farmaci con tecnologia a Rna. I migliori tre progetti di ricerca riceveranno un contributo in denaro fino a 40.000 euro a fondo perduto.

Le candidature sono aperte dal 3 novembre 2025 fino al 9 gennaio 2026, ore 23:59 CET

• Gli esiti della selezione sono comunicati entro il 21 dicembre 2025.
• La Deal Line up, che richiede la disponibilità del candidato per uno slot di 30 minuti, si svolge entro il 18 gennaio 2026.
• La premiazione avverrà entro il 31 gennaio 2026.

I progetti devono essere attinenti ad almeno uno degli ambiti di riferimento dei 10 Spoke del Centro Nazionale RNA&GeneTherapy elencati di seguito:

Spoke 1 - Genetic Diseases
Spoke 2 - Cancer
Spoke 3 – Neurodegeneration
Spoke 4 - Metabolic and Cardiovascular Diseases
Spoke 5 - Inflammatory and Infectious Diseases
Spoke 6 - RNA Drug Development
Spoke 7 – Biocomputing
Spoke 8 - Platforms for RNA/DNA Delivery
Spoke 9 - Competence Center on RNA Drug Pharmacology
Spoke 10 - Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP

Tutte le informazioni e il regolamento sono disponibili alla pagina web dedicata dalla quale è possibile scaricare il form di candidatura, e accedere alla procedura di candidatura online.

[safe_summary] => ) ) ) [field_date_box_lancio_news] => Array ( [und] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) ) [field_etichetta_box_lancio_news] => Array ( ) [field_img_box_lancio_news] => Array ( [und] => Array ( [0] => Array ( [fid] => 143846 [uid] => 26499 [filename] => RNA.jpg [uri] => public://RNA.jpg [filemime] => image/jpeg [filesize] => 439007 [status] => 1 [timestamp] => 1762505917 [type] => image [field_file_image_alt_text] => Array ( ) [field_file_image_title_text] => Array ( ) [field_folder] => Array ( [und] => Array ( [0] => Array ( [tid] => 2048 ) ) ) [metadata] => Array ( [height] => 631 [width] => 1200 ) [height] => 631 [width] => 1200 [alt] => rna al microscopio [title] => ) ) ) [field_link_alla_news] => Array ( ) [field_link_esterno_news] => Array ( ) [field_pagina_associata] => Array ( ) [field_link_etichetta] => Array ( ) [field_abstract_news] => Array ( [und] => Array ( [0] => Array ( [value] => Il Centro Nazionale per la Terapia Genica e Farmaci RNA in collaborazione con Intesa Sanpaolo Innovation Center, lanciano GeneRNAtion Challenge, per promuovere le migliori startup e i migliori progetti innovativi nel campo della Tecnologia a RNA e della Terapia Genica [format] => [safe_value] => Il Centro Nazionale per la Terapia Genica e Farmaci RNA in collaborazione con Intesa Sanpaolo Innovation Center, lanciano GeneRNAtion Challenge, per promuovere le migliori startup e i migliori progetti innovativi nel campo della Tecnologia a RNA e della Terapia Genica ) ) ) [field_allegato_news] => Array ( ) [field_categorie_news] => Array ( [und] => Array ( [0] => Array ( [tid] => 2264 ) [1] => Array ( [tid] => 2266 ) [2] => Array ( [tid] => 2267 ) [3] => Array ( [tid] => 2462 ) ) ) [field_pub_date] => Array ( [und] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [value2] => 2025-11-30T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) ) [field_layout_news] => Array ( [und] => Array ( [0] => Array ( [value] => single ) ) ) [field_testo_opzionale_news] => Array ( ) [field_url_en_page] => Array ( [und] => Array ( [0] => Array ( [value] => https://www.unipd.it/news/genernation-challenge-advancing-personalized-medicine-0 [format] => [safe_value] => https://www.unipd.it/news/genernation-challenge-advancing-personalized-medicine-0 ) ) ) [field_url_en_page_label] => Array ( [und] => Array ( [0] => Array ( [value] => English version [format] => [safe_value] => English version ) ) ) [path] => Array ( [pathauto] => 1 ) [name] => rossella.vezzosi [picture] => 0 [data] => b:0; [num_revisions] => 5 [current_revision_id] => 511474 [is_current] => 1 [is_pending] => [revision_moderation] => [entity_view_prepared] => 1 ) [#items] => Array ( [0] => Array ( [value] => Il Centro Nazionale per la Terapia Genica e Farmaci RNA in collaborazione con Intesa Sanpaolo Innovation Center, lanciano GeneRNAtion Challenge, per promuovere le migliori startup e i migliori progetti innovativi nel campo della Tecnologia a RNA e della Terapia Genica [format] => [safe_value] => Il Centro Nazionale per la Terapia Genica e Farmaci RNA in collaborazione con Intesa Sanpaolo Innovation Center, lanciano GeneRNAtion Challenge, per promuovere le migliori startup e i migliori progetti innovativi nel campo della Tecnologia a RNA e della Terapia Genica ) ) [#formatter] => text_default [0] => Array ( [#markup] => Il Centro Nazionale per la Terapia Genica e Farmaci RNA in collaborazione con Intesa Sanpaolo Innovation Center, lanciano GeneRNAtion Challenge, per promuovere le migliori startup e i migliori progetti innovativi nel campo della Tecnologia a RNA e della Terapia Genica ) ) [links] => Array ( [#theme] => links__node [#pre_render] => Array ( [0] => drupal_pre_render_links ) [#attributes] => Array ( [class] => Array ( [0] => links [1] => inline ) ) [node] => Array ( [#theme] => links__node__node [#links] => Array ( [node-readmore] => Array ( [title] => Read more about GeneRNAtion Challenge - Advancing Personalized Medicine [href] => node/121951 [html] => 1 [attributes] => Array ( [rel] => tag [title] => GeneRNAtion Challenge - Advancing Personalized Medicine ) ) ) [#attributes] => Array ( [class] => Array ( [0] => links [1] => inline ) ) ) ) [field_date_box_lancio_news] => Array ( [#theme] => field [#weight] => 1 [#title] => Data [#access] => 1 [#label_display] => above [#view_mode] => teaser [#language] => und [#field_name] => field_date_box_lancio_news [#field_type] => date [#field_translatable] => 0 [#entity_type] => node [#bundle] => box_lancio_news [#object] => stdClass Object ( [vid] => 511474 [uid] => 26499 [title] => GeneRNAtion Challenge - Advancing Personalized Medicine [log] => [status] => 1 [comment] => 0 [promote] => 1 [sticky] => 0 [nid] => 121951 [type] => box_lancio_news [language] => it [created] => 1762505917 [changed] => 1764252889 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1764252889 [revision_uid] => 26499 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>

Il Centro Nazionale per la Terapia Genica e Farmaci RNA, in collaborazione con Intesa Sanpaolo Innovation Center, annuncia il lancio della prima edizione della GeneRNAtion Challenge - Advancing Personalized Medicine. Questo evento rappresenta un'opportunità unica per promuovere le migliori startup e i progetti più innovativi nel campo della tecnologia a Rna e della terapia Genica.

Le migliori otto startup selezionate avranno accesso a un contributo in denaro fino a 110.000 euro a fondo perduto e a tre anni di quota di partecipazione alla Fondazione centro nazionale per lo sviluppo di terapia genica e farmaci con tecnologia a Rna. I migliori tre progetti di ricerca riceveranno un contributo in denaro fino a 40.000 euro a fondo perduto.

Le candidature sono aperte dal 3 novembre 2025 fino al 9 gennaio 2026, ore 23:59 CET

• Gli esiti della selezione sono comunicati entro il 21 dicembre 2025.
• La Deal Line up, che richiede la disponibilità del candidato per uno slot di 30 minuti, si svolge entro il 18 gennaio 2026.
• La premiazione avverrà entro il 31 gennaio 2026.

I progetti devono essere attinenti ad almeno uno degli ambiti di riferimento dei 10 Spoke del Centro Nazionale RNA&GeneTherapy elencati di seguito:

Spoke 1 - Genetic Diseases
Spoke 2 - Cancer
Spoke 3 – Neurodegeneration
Spoke 4 - Metabolic and Cardiovascular Diseases
Spoke 5 - Inflammatory and Infectious Diseases
Spoke 6 - RNA Drug Development
Spoke 7 – Biocomputing
Spoke 8 - Platforms for RNA/DNA Delivery
Spoke 9 - Competence Center on RNA Drug Pharmacology
Spoke 10 - Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP

Tutte le informazioni e il regolamento sono disponibili alla pagina web dedicata dalla quale è possibile scaricare il form di candidatura, e accedere alla procedura di candidatura online.

[summary] => [format] => 2 [safe_value] =>

Il Centro Nazionale per la Terapia Genica e Farmaci RNA, in collaborazione con Intesa Sanpaolo Innovation Center, annuncia il lancio della prima edizione della GeneRNAtion Challenge - Advancing Personalized Medicine. Questo evento rappresenta un'opportunità unica per promuovere le migliori startup e i progetti più innovativi nel campo della tecnologia a Rna e della terapia Genica.

Le migliori otto startup selezionate avranno accesso a un contributo in denaro fino a 110.000 euro a fondo perduto e a tre anni di quota di partecipazione alla Fondazione centro nazionale per lo sviluppo di terapia genica e farmaci con tecnologia a Rna. I migliori tre progetti di ricerca riceveranno un contributo in denaro fino a 40.000 euro a fondo perduto.

Le candidature sono aperte dal 3 novembre 2025 fino al 9 gennaio 2026, ore 23:59 CET

• Gli esiti della selezione sono comunicati entro il 21 dicembre 2025.
• La Deal Line up, che richiede la disponibilità del candidato per uno slot di 30 minuti, si svolge entro il 18 gennaio 2026.
• La premiazione avverrà entro il 31 gennaio 2026.

I progetti devono essere attinenti ad almeno uno degli ambiti di riferimento dei 10 Spoke del Centro Nazionale RNA&GeneTherapy elencati di seguito:

Spoke 1 - Genetic Diseases
Spoke 2 - Cancer
Spoke 3 – Neurodegeneration
Spoke 4 - Metabolic and Cardiovascular Diseases
Spoke 5 - Inflammatory and Infectious Diseases
Spoke 6 - RNA Drug Development
Spoke 7 – Biocomputing
Spoke 8 - Platforms for RNA/DNA Delivery
Spoke 9 - Competence Center on RNA Drug Pharmacology
Spoke 10 - Pre-clinical Development, GMP Manufacturing and Clinical Trials of GTMP

Tutte le informazioni e il regolamento sono disponibili alla pagina web dedicata dalla quale è possibile scaricare il form di candidatura, e accedere alla procedura di candidatura online.

[safe_summary] => ) ) ) [field_date_box_lancio_news] => Array ( [und] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) ) [field_etichetta_box_lancio_news] => Array ( ) [field_img_box_lancio_news] => Array ( [und] => Array ( [0] => Array ( [fid] => 143846 [uid] => 26499 [filename] => RNA.jpg [uri] => public://RNA.jpg [filemime] => image/jpeg [filesize] => 439007 [status] => 1 [timestamp] => 1762505917 [type] => image [field_file_image_alt_text] => Array ( ) [field_file_image_title_text] => Array ( ) [field_folder] => Array ( [und] => Array ( [0] => Array ( [tid] => 2048 ) ) ) [metadata] => Array ( [height] => 631 [width] => 1200 ) [height] => 631 [width] => 1200 [alt] => rna al microscopio [title] => ) ) ) [field_link_alla_news] => Array ( ) [field_link_esterno_news] => Array ( ) [field_pagina_associata] => Array ( ) [field_link_etichetta] => Array ( ) [field_abstract_news] => Array ( [und] => Array ( [0] => Array ( [value] => Il Centro Nazionale per la Terapia Genica e Farmaci RNA in collaborazione con Intesa Sanpaolo Innovation Center, lanciano GeneRNAtion Challenge, per promuovere le migliori startup e i migliori progetti innovativi nel campo della Tecnologia a RNA e della Terapia Genica [format] => [safe_value] => Il Centro Nazionale per la Terapia Genica e Farmaci RNA in collaborazione con Intesa Sanpaolo Innovation Center, lanciano GeneRNAtion Challenge, per promuovere le migliori startup e i migliori progetti innovativi nel campo della Tecnologia a RNA e della Terapia Genica ) ) ) [field_allegato_news] => Array ( ) [field_categorie_news] => Array ( [und] => Array ( [0] => Array ( [tid] => 2264 ) [1] => Array ( [tid] => 2266 ) [2] => Array ( [tid] => 2267 ) [3] => Array ( [tid] => 2462 ) ) ) [field_pub_date] => Array ( [und] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [value2] => 2025-11-30T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) ) [field_layout_news] => Array ( [und] => Array ( [0] => Array ( [value] => single ) ) ) [field_testo_opzionale_news] => Array ( ) [field_url_en_page] => Array ( [und] => Array ( [0] => Array ( [value] => https://www.unipd.it/news/genernation-challenge-advancing-personalized-medicine-0 [format] => [safe_value] => https://www.unipd.it/news/genernation-challenge-advancing-personalized-medicine-0 ) ) ) [field_url_en_page_label] => Array ( [und] => Array ( [0] => Array ( [value] => English version [format] => [safe_value] => English version ) ) ) [path] => Array ( [pathauto] => 1 ) [name] => rossella.vezzosi [picture] => 0 [data] => b:0; [num_revisions] => 5 [current_revision_id] => 511474 [is_current] => 1 [is_pending] => [revision_moderation] => [entity_view_prepared] => 1 ) [#items] => Array ( [0] => Array ( [value] => 2025-11-07T00:00:00 [timezone] => Europe/Paris [timezone_db] => Europe/Paris [date_type] => date ) ) [#formatter] => date_default [0] => Array ( [#markup] => Ven, 07/11/2025 ) ) )